Related Experiment Video
Updated: Jan 7, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.7K
Systemic Sclerosis-Recent Advances in Diagnosis and Management
William J Kerrigan1, Alistair C Church1,2, Ariane L Herrick3,4
1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, NHS Golden Jubilee, Glasgow, UK.
British Journal of Hospital Medicine (London, England : 2005)
|December 24, 2025
Summary
Systemic sclerosis treatment has advanced significantly, with new options for early diffuse disease, digital ulcers, lung disease, and pulmonary arterial hypertension. Ongoing research promises further progress in managing this complex connective tissue disease.
Area of Science:
- Rheumatology
- Immunology
- Pulmonology
Background:
- Systemic sclerosis is a severe multisystem connective tissue disease.
- It presents significant morbidity and mortality.
- Recent therapeutic progress has been substantial.
Purpose of the Study:
- To provide an overview of systemic sclerosis.
- To highlight recent advances in managing specific complications.
- To focus on early diffuse cutaneous disease, digital vasculopathy, interstitial lung disease, and pulmonary arterial hypertension.
Main Methods:
- Review of recent scientific literature and clinical trial data.
- Synthesis of information on emerging and established therapies.
- Focus on evidence-based treatment strategies.
Main Results:
- Autologous hematopoietic stem cell transplantation is an option for select early diffuse systemic sclerosis patients.
- Phosphodiesterase type 5 inhibitors and bosentan improve digital ulceration.
- Understanding of immunosuppressants and antifibrotics for interstitial lung disease has improved.
- Early combination therapies are increasingly used for pulmonary arterial hypertension.
Conclusions:
- Substantial advances have been made in managing systemic sclerosis.
- Current therapeutic strategies offer improved outcomes for key complications.
- Ongoing clinical trials are expected to yield further therapeutic innovations.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
179
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
179
01:26Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291
01:21Rheumatic Heart Disease III: Medical Management
263
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
263
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
439
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
439
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:24Cystic Fibrosis: Management
438
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
438